Well, this is better than expected. None of the biomarkers in ANY of the 18 patients increased. And this is not including the highest 1800mg dose.
Given the establish safety profile of Veyonda, the path to commercialisation here could be short.
But really, better than that is the potential number of lives saved if this translates to clinical outcomes.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda Showing Potential to Prevent Cytokine Storm
Ann: Veyonda Showing Potential to Prevent Cytokine Storm, page-6
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
-0.004(5.71%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 6.6¢ | $3.396K | 49.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 57227 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 11999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 57227 | 0.066 |
2 | 22703 | 0.065 |
2 | 32786 | 0.061 |
4 | 105033 | 0.060 |
3 | 136932 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 11999 | 1 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 75689 | 4 |
Last trade - 10.52am 05/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |